Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Earnings Preview: Altice USA, Inc. (ATUS) Q1 Earnings Expected to Decline
Earnings Preview: Altice USA, Inc. (ATUS) Q1 Earnings Expected to Decline

The market expects Altice USA, Inc. (ATUS) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Affirm Holdings (AFRM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Affirm Holdings (AFRM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Wall Street expects a year-over-year increase in earnings on higher revenues when Affirm Holdings (AFRM) reports results for the quarter ended March 2025. While this widely-known consensus outlook

Astrana Health, Inc. (ASTH) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Astrana Health, Inc. (ASTH) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

The market expects Astrana Health, Inc. (ASTH) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known

Akamai Technologies (AKAM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Akamai Technologies (AKAM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Wall Street expects a year-over-year decline in earnings on higher revenues when Akamai Technologies (AKAM) reports results for the quarter ended March 2025. While this widely-known consensus

Akebia Therapeutics (AKBA) Expected to Beat Earnings Estimates: Should You Buy?
Akebia Therapeutics (AKBA) Expected to Beat Earnings Estimates: Should You Buy?

Akebia Therapeutics (AKBA) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Appian (APPN) Earnings Expected to Grow: Should You Buy?
Appian (APPN) Earnings Expected to Grow: Should You Buy?

The market expects Appian (APPN) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is

Analysts Estimate Wave Life Sciences (WVE) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Wave Life Sciences (WVE) to Report a Decline in Earnings: What to Look Out for

Wave Life Sciences (WVE) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook

Wolverine World Wide (WWW) Earnings Expected to Grow: Should You Buy?
Wolverine World Wide (WWW) Earnings Expected to Grow: Should You Buy?

Wolverine World Wide (WWW) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Clear Secure (YOU) Earnings Expected to Grow: Should You Buy?
Clear Secure (YOU) Earnings Expected to Grow: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when Clear Secure (YOU) reports results for the quarter ended March 2025. While this widely-known consensus outlook is

Analysts Estimate ZipRecruiter, Inc. (ZIP) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate ZipRecruiter, Inc. (ZIP) to Report a Decline in Earnings: What to Look Out for

The market expects ZipRecruiter, Inc. (ZIP) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Analysts Estimate Crocs (CROX) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Crocs (CROX) to Report a Decline in Earnings: What to Look Out for

Crocs (CROX) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a good

Coinbase Global, Inc. (COIN) Reports Next Week: Wall Street Expects Earnings Growth
Coinbase Global, Inc. (COIN) Reports Next Week: Wall Street Expects Earnings Growth

The market expects Coinbase Global, Inc. (COIN) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known

Compass, Inc. (COMP) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Compass, Inc. (COMP) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

The market expects Compass, Inc. (COMP) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Collegium Pharmaceutical (COLL) Expected to Beat Earnings Estimates: Should You Buy?Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Collegium Pharmaceutical (COLL) Expected to Beat Earnings Estimates: Should You Buy?

Wall Street expects a year-over-year decline in earnings on higher revenues when Collegium Pharmaceutical (COLL) reports results for the quarter ended March 2025. While this widely-known consensus

Wheaton Precious Metals Corp. (WPM) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleasePhoto, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
Wheaton Precious Metals Corp. (WPM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

The market expects Wheaton Precious Metals Corp. (WPM) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known

CG Oncology, Inc. (CGON) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
CG Oncology, Inc. (CGON) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

CG Oncology, Inc. (CGON) is expected to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended March 2025. This widely-known

Restaurant Brands (QSR) Earnings Expected to Grow: Should You Buy?Photo, wide shot, wide-angle lens,  Clothing manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.midjourneyapi.xyz/temp/7d69264d-49b2-466c-9987-b2706836d522.png
Restaurant Brands (QSR) Earnings Expected to Grow: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when Restaurant Brands (QSR) reports results for the quarter ended March 2025. While this widely-known consensus outlook

Will Clearside Biomedical, Inc. (CLSD) Report Negative Q1 Earnings? What You Should Know
Will Clearside Biomedical, Inc. (CLSD) Report Negative Q1 Earnings? What You Should Know

Wall Street expects a year-over-year increase in earnings on higher revenues when Clearside Biomedical, Inc. (CLSD) reports results for the quarter ended March 2025. While this widely-known

Cogent Communications (CCOI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Cogent Communications (CCOI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Cogent Communications (CCOI) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Warner Music Group Corp. (WMG) Reports Next Week: Wall Street Expects Earnings Growth
Warner Music Group Corp. (WMG) Reports Next Week: Wall Street Expects Earnings Growth

Warner Music Group Corp. (WMG) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

NCR Voyix (VYX) Expected to Beat Earnings Estimates: Should You Buy?
NCR Voyix (VYX) Expected to Beat Earnings Estimates: Should You Buy?

The market expects NCR Voyix (VYX) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is

Prestige Consumer Healthcare (PBH) Reports Next Week: Wall Street Expects Earnings GrowthPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Prestige Consumer Healthcare (PBH) Reports Next Week: Wall Street Expects Earnings Growth

Prestige Consumer Healthcare (PBH) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known

Warner Bros. Discovery (WBD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Warner Bros. Discovery (WBD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Wall Street expects a year-over-year increase in earnings on lower revenues when Warner Bros. Discovery (WBD) reports results for the quarter ended March 2025. While this widely-known consensus

Tapestry (TPR) Earnings Expected to Grow: Should You Buy?
Tapestry (TPR) Earnings Expected to Grow: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when Tapestry (TPR) reports results for the quarter ended March 2025. While this widely-known consensus outlook is

10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Wall Street expects a year-over-year increase in earnings on lower revenues when 10x Genomics (TXG) reports results for the quarter ended March 2025. While this widely-known consensus outlook is